Twist Bioscience (TWST)
(Delayed Data from NSDQ)
$43.66 USD
+1.20 (2.83%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $43.63 -0.03 (-0.07%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth C Momentum C VGM
Price, Consensus and EPS Surprise
TWST 43.66 +1.20(2.83%)
Will TWST be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TWST based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TWST
Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates
Should You Invest in the SPDR S&P Biotech ETF (XBI)?
TWST: What are Zacks experts saying now?
Zacks Private Portfolio Services
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
Will Castle Biosciences, Inc. (CSTL) Report Negative Earnings Next Week? What You Should Know
Other News for TWST
Analysts Offer Insights on Healthcare Companies: CureVac (CVAC), Vericel (VCEL) and Twist Bioscience (TWST)
Invesco Small Cap Growth Fund Q2 2024 Review
Invesco Main Street Small Cap Fund Q2 2024 Review
Twist Bioscience Expands Gene Offering With Long Gene Fragments up to 5.0kb
Analysts Have Conflicting Sentiments on These Healthcare Companies: Merus (MRUS), Twist Bioscience (TWST) and Owens & Minor (OMI)